Automation Hero Joins AWS Marketplace, Empowering End-to-end Intelligent Document Processing

Automation Hero AWS Partner

Automation Hero is now available in the AWS Marketplace.

SAN FRANCISCO and BERLIN and LONDON, June 06, 2023 (GLOBE NEWSWIRE) — Businesses are struggling to find effective technology that can process the unprecedented rise of unstructured and semi-structured data (email, PDFs, images, invoices, handwritten documents, contracts, forms, and more).

To solve this challenge, Automation Hero is now available for purchase in AWS Marketplace – providing AWS customers immediate access to advanced AI technology that automates manual, time-consuming and expensive document-centric processes. This will bring new levels of automation and efficiency to businesses across industries, including insurance, real estate, finance, healthcare, telco and more.

Automation Hero’s all-in-one platform, now running on AWS, enables organizations to process more diverse and complex sets of documents with above-human accuracy. Its no-code approach democratizes access to AI for subject matter experts who no longer need to rely on IT or data science resources. Users can easily take advantage of patent-pending AI document processing and large language model (GPT-like LLMs) understanding capabilities, including, but not limited to:

  • typed and handwritten OCR
  • table detection and extraction
  • signature detection and extraction
  • structured data / named entity extraction
  • classification
  • text summarization, and
  • document separation

These can be integrated with legacy systems for more data access, complex data and business workflows, human-in-the-loop verification and process analytics to build highly automated, autonomous, and monitorable business processes.

“We’re excited to leverage the power of Automation Hero and AWS to streamline our claims process and reduce manual effort,” said Eoin Grace, Deputy Head of IT at Markerstudy. “Now, we can handle large volumes of claims with speed and accuracy, delivering a better customer experience.”

Until now, companies have struggled to achieve anywhere near 100% fully automated document processing because existing solutions cannot process the wide variety of data often locked within documents. This detrimentally impacts business processes such as underwriting, claims processing, property management, mortgage processing, accounts payable, and compliance.

“We are incredibly excited to work with the leading cloud provider on this next step of our solution,” said Stefan Groschupf, Founder and CEO of Automation Hero. “We’re bringing a new level of access to data and insights trapped in business documents that will be a treasure trove for companies looking to outpace their competition.”

Since its founding in 2017, Automation Hero has been on a meteoric rise, earning the trust of global leaders and members of the Fortune 500 list. Additional recent industry traction includes being named an industry leader in GigaOm’s IDP Radar Report, along with two prominent innovation awards from analyst firms Deep Analysis and Intellyx.

For more information, please visit our Intelligent Automation Solutions on AWS website.

About Automation Hero
Automation Hero helps organizations process any type of document faster than ever with the most powerful and complete intelligent document processing platform. It offers the easiest-to-use and most accurate AI in the industry so companies can instead focus on accelerating business processes to stay competitive. The company was built by a world-class team of sales and AI experts, many of whom were on the founding team of Datameer, the leader in big data analytics. Visit for more information and follow the company’s blog and LinkedIn.

Monique Sherman
Head of Marketing, Automation Hero

A photo accompanying this announcement is available at

GlobeNewswire Distribution ID 8852646

VCI Global Declares Interim Dividend And Firms Up Dividend Policy

KUALA LUMPUR, Malaysia, June 06, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) has declared a first single tier interim dividend of USD0.01 per ordinary share. The payout is the Company’s way of rewarding its shareholders for their support over the years.

The dividend will be paid out on Monday, 31 July 2023 to the shareholders whose names are on the record at the close of business on Monday, 3 July 2023. The ex-date is Friday, 30 June 2023.

VCI Global also announced a change in its dividend policy where dividend will be paid on a regular basis at the end of each financial year. This is notwithstanding interim dividends which may be declared intermittently. The Company’s Board of Directors shall hold sole discretion on the quantum to be paid to the shareholders. As for the half yearly financial results, it will be announced early August each year.

“High growth companies, like VCI (Global), have generally not been known to be dividend paymasters. This payout is to show investors our solid financial health and to meet the needs of balancing between rewarding shareholders and ensuring the company’s growth. In the quest for growth, the support of the shareholders must not be taken for granted. The shareholders might well understand the need to preserve funds for expansions, their sacrifices nonetheless need to be remunerated,” said Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global.

About VCI Global Limited

VCI Global is a multi-disciplinary consulting group with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor relation services, and technology consultancy services. Its clients range from small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from Malaysia, but also serves some clients from China, Singapore, and the US.

For more information on the Company, please log on to

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.


Issued by Imej Jiwa Communications Sdn Bhd on behalf of VCI Global Limited
For media queries, please contact:

Imej Jiwa Communications Sdn Bhd
Chris Chuah

GlobeNewswire Distribution ID 8853218

Vectara now available with LangChain

Vectara and LangChain announce integration of Vectara state-of-the-art retrieval engine with LangChain’s flexible open-source framework for building LLM-powered applications

SANTA CLARA, Calif., June 06, 2023 (GLOBE NEWSWIRE) — Vectara, the Generative AI (GenAI) conversational search platform, announces its integration with LangChain, a leading open-source project for building LLM-powered applications.

With this integration, LangChain developers can have immediate access to Vectara’s platform for “Grounded Generation,” which features high-precision search results, including both neural and hybrid search, and improves the accuracy to be included in retrieval-augmented generation.

“One of the trickiest things in building retrieval augmented generation applications is getting the retrieval part right,” said Amin Ahmad, Co-founder and CTO of Vectara. “We have carefully optimized our dual encoder retrieval system and added in hybrid search to ensure the absolute best results for retrieval. With the LangChain integration, we are now enabling this innovation to the large community of LangChain developers.”

LangChain has a vibrant community of developers who continue to add innovative capabilities to the project such as new components, chain types, prompts and vector databases.

“We are thrilled to have this integration with Vectara. Vectara is more than just a vector database – it takes care of many details like performance, privacy and security behind the scenes, so that LangChain developers can focus on the functionality of their application,” said Harrison Chase, CEO and co-founder of LangChain.

As many enterprises work to integrate LLM applications into their internal systems and within their product offerings, one key concern is data privacy. Vectara’s platform does not train its models on its customers’ data. That, along with Vectara’s enterprise-grade security controls, provide CISOs and CIOs the peace of mind they need to deploy these new types of unique applications in their respective organizations.

“I am very excited about this integration with LangChain, as it allows applications developed with LangChain to quickly mature into large-scale enterprise applications,” said head of developer relations at Vectara Ofer Mendelevitch. “Together with LangChain, Vectara is making advanced AI accessible to developers across all industries and helping drive the next wave of innovation. “

About Vectara
Vectara is a GenAI conversational search and discovery platform that allows businesses to have intelligent conversations utilizing their own data (think ChatGPT but for your data). Developer-first, the platform provides an easy-to-use API and gives developers access to cutting-edge NLU (Natural Language Understanding) technology with industry-leading relevance. The platform ensures data security and privacy with strong encryption while ensuring no customer data is used for training models. With Vectara’s Grounded Generation, businesses can quickly and affordably integrate best-in-class search and question answering into their application, knowledge base, website, chatbot, or support helpdesk.

About LangChain
LangChain is an open source project aimed at assisting in the development of powerful LLM-powered applications by combining and chaining components such as prompts, vector databases, and LLMs together into coherent applications.

Media Contact
Carly Bourne

GlobeNewswire Distribution ID 8852815

Fortinet Research Finds Over 80% of Organizations Experience Cyberattacks that Target Employees

New research underscores importance of effective cyber awareness training for employees to decrease cyber risks, with more than 50% of leaders indicating their employees lack proper knowledge

SUNNYVALE, Calif., June 06, 2023 (GLOBE NEWSWIRE) —

John Maddison, EVP of Products and CMO at Fortinet
“Our 2023 Security Awareness and Training Global Research Brief underscores the crucial role employees play in preventing cyberattacks. It also highlights the critical need for organizations to prioritize security awareness and training services to ensure employees serve as the first line of defense.”

News Summary
Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today released its 2023 Security Awareness and Training Global Research Brief, highlighting the importance of organizations building a cyber-aware workforce to strengthen their security posture and reduce cyberattacks.

Enabling Employees to Protect their Organization’s Most Critical Digital Assets
Organizations are grappling with an increasingly sophisticated threat landscape. The most recent Global Threat Landscape Report from Fortinet’s FortiGuard Labs found that ransomware threats remain at peak levels with no evidence of slowing down globally. At the same time, Fortinet’s 2023 Cybersecurity Skills Gap Global Report found that 84% of organizations experienced one or more breaches in 2022.

And now the latest research from Fortinet’s 2023 Security Awareness and Training Global Research Brief reveals that more than 90% of leaders believe that increased employee cybersecurity awareness would help decrease the occurrence of cyberattacks. As organizations face increasing cyber risks, the research highlights the important role of employees in serving as an organization’s first line of defense in protecting their organization from cybercrime. Additional key findings from Fortinet’s research include:

  • Employees are being targeted by cyber criminals. The research found that 81% of organizations faced malware, phishing, and password attacks last year which mainly were targeted at users. This underscores that employees can be an organization’s weakest point or one of its most powerful defenses.
  • Having an effective training program is key to instilling good cyber hygiene in employees. Eighty-five percent of leaders say their organization has a security awareness and training program, yet more than 50% believe their employees still lack cybersecurity knowledge. This gap suggests the training programs in place may not be as effective as they could be, resulting in inconsistency in how employees apply good cyber hygiene practices or that training is not reinforced sufficiently.
  • Cybersecurity is increasingly becoming a priority for the Board of Directors. The report found that 93% of organizations indicated their board of directors are asking about the organizations cyber defenses and strategy.

Building a Cyber Aware Workforce with Fortinet’s Security Awareness and Training Service
For organizations looking to implement cybersecurity awareness training for their employees or those evaluating the effectiveness of their current program, Fortinet offers its Security Awareness and Training service to develop a cyber-aware workforce. Designed by the Fortinet Training Institute’s world-class trainers, the service covers a broad range of topics in a practical way and reinforces learnings with reminders and checks, helping to improve training outcomes. Organizations deploying the service also have access to a dashboard and reporting to address cyber insurance and compliance needs.

The service uniquely leverages FortiGuard Labs threat intelligence, providing frequently updated training informed by developments observed across the threat landscape. Additionally, the service aligns with the National Institute of Standards and Technology (NIST) guidelines – NIST 800-50 and NIST 800-16 – to further ensure key topics are covered including, information security, data privacy, physical security, password protection and internet security.

Fortinet has also tailored this service for educators and made it available for free to school districts and systems across the United States and local education authorities in the United Kingdom, with plans to continue increasing access globally.

About the Fortinet Cyber Awareness Survey:

  • The survey was conducted among more than 1,800 IT and/or cybersecurity decision-makers from 29 different locations.
  • Survey respondents came from a range of industries, including technology (21%), manufacturing (16%), and financial services (13%).

Additional Resources

About Fortinet
Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere you need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at, the Fortinet Blog, and FortiGuard Labs.


Copyright © 2023 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiCWP, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFone, FortiGSLB, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMoM, FortiMonitor, FortiNAC, FortiNDR, FortiPenTest, FortiPhish, FortiPlanner, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM and FortiXDR. Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

Media Contact: Investor Contact: Analyst Contact:
Stephanie Lira
Fortinet, Inc.
Peter Salkowski
Fortinet, Inc.
Brian Greenberg
Fortinet, Inc.

GlobeNewswire Distribution ID 8852874

Madison Realty Capital Originates $262 Million Construction Loan for E11EVEN Residences Beyond Luxury Condominiums in Miami

NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced it has originated a $262 million construction loan to developers PMG and E11EVEN Partners for E11EVEN Residences Beyond, an ultra-luxury, dual-tower development located in Miami’s District 11 neighboring the E11EVEN Hotel & Residences Miami development.

Josh Zegen, Managing Principal and Co-Founder of Madison Realty Capital, said, “We are excited to draw from our significant expertise and scale in the Miami market to work with PMG and E11even Partners to deliver an exciting new luxury residence centrally located in Miami’s vibrant District 11. PMG has already successfully presold 83% of residences to date as Miami continues to attract major businesses and demand from professionals seeking highly amenitized housing options continues to rise. PMG has decades of experience and development expertise in Miami, and we are pleased to work with them again to deliver a flexible financing solution for E11even Residences Beyond.”

“It is an exciting time to be in Miami’s burgeoning District 11, as evidenced by strong sales and continued support from top lenders such as Madison Realty Capital. Together with our partners, we are thrilled to have reached this important milestone, as we embark on our journey in building E11EVEN Residences Beyond,” said Andrew Warman, Managing Director at PMG.

“We are confident that E11EVEN Residences Beyond will enhance the neighborhood, seamlessly blending exclusive residential ambiance with exceptional entertainment, exquisite dining, and the dynamic energy District 11 is renowned for. With this loan secured, we are eager to welcome future residents to this extraordinary project and deliver an unparalleled, VIP experience,” added Ryan Shear, Managing Partner at PMG.

Centrally located in Downtown Miami’s District 11, E11EVEN Residences Beyond and E11EVEN Hotel & Residences Miami offer a resort-style, entertainment-driven experience and destination – the first of its kind in the Southeastern United States. Floor plans at both of its towers range from studios to two bedrooms in addition to a presidential collection and penthouse suites. Each unit comes equipped with fully-integrated “smart building” features, Subzero and Wolf appliances, custom ITALKRAFT Italian cabinetry, top-level finishes, and designer-curated furnishings. The soaring 65-story towers will be designed by internationally renowned Sieger Suarez Architects with interiors by award-winning design firm AvroKO. E11EVEN Partners Marc Roberts, Michael Simkins, and Dennis DeGori and PMG partners Kevin Maloney, Ryan Shear and Dan Kaplan are the developers behind the E11EVEN Hotel & Residences development.

Amenities for E11EVEN Residences Beyond and E11EVEN Hotel & Residences include a Chopra Spa & Studio, a five-star restaurant collection by Riviera Dining Group, a casino-style sports lounge, a med spa, a rooftop pool and bar, an E11EVEN day club and pool on the 11th floor, and both a second-floor restaurant with a ground-floor escalator entrance for direct access and an upscale lounge and private membership club located on the tower’s rooftop, created by Riviera Dining Group.

In addition to the amenities at the E11even Hotel & Residences, buyers at E11EVEN Residences Beyond will have exclusive access to the E11EVEN Beyond Members Social Club and private facilities including a helipad, a signature restaurant, fully staffed executive office suites, a state-of-the-art fitness center, an expanded resort-style pool, and The Clayton, an ultra-premium social club.

The transaction was brokered by Jones Lang LaSalle (NYSE: JLL).

For more information on E11EVEN Hotel & Residences, please visit

About Madison Realty Capital
Madison Realty Capital is a vertically integrated real estate private equity firm that, as of March 31, 2023, manages $10 billion in assets on behalf of a global institutional investor base. Since 2004, Madison Realty Capital has completed $23 billion of real estate transactions largely through direct lending to borrowers with flexible and highly customized financing solutions. Madison Realty Capital’s strong underwriting capabilities provide certainty of execution in complex, time sensitive situations. Headquartered in New York City, with offices in Los Angeles, Dallas, and Israel, the firm has 75 employees across its real estate investment, asset management, and development disciplines. Madison Realty Capital has been named to Commercial Observer’s prestigious “Power 100” list of New York City real estate players every year since 2016 and was recognized in March 2023 by PERE as the Debt Firm of the Year, North America for Fiscal Year 2022. To learn more, follow us on LinkedIn and visit

About PMG
Founded in 1991 by Kevin Maloney, Property Markets Group (PMG) has evolved from a local New York City based real estate operator to a national investment, development, and asset management firm focused on large scale multifamily and for-sale condominium projects, as well as select high-performing commercial holdings.

Today PMG is run by Managing Partners Ryan Shear and Dan Kaplan, currently operating across Florida, New York, Colorado, Tennessee, and Georgia. Their vertically integrated team has departments specializing in acquisitions and land use, design and architecture, construction management, capital markets, asset management, sales and marketing, as well as significant in-house legal and accounting capabilities.

PMG’s current multi-billion dollar nationwide portfolio includes assets across pre-development, construction, lease-up, and sell out, totaling more than 8,500 residential units and over 16 million square feet of development. Notable rental projects under the Society Living brand platform include locations in Denver, Nashville, Atlanta, Brooklyn, Orlando, Fort Lauderdale and Miami. Notable current condominium projects include 111 West 57th Street in New York City; E11EVEN Hotel & Residences, Waldorf Astoria Hotel & Residences and The Elser Hotel & Residences in Miami; as well as Sage Longboat Key Residences and One Park Sarasota on Florida’s west coast. Additionally, PMG is growing its Affordable Housing division nationally. For more information, visit

About E11EVEN Partners
E11EVEN PARTNERS is a leading hospitality, lifestyle, and entertainment company based in Miami, Florida. Led by Dennis DeGori, Michael Simkins, and Marc Roberts, along with operating partners Gino LoPinto, Daniel Solomon, Ken DeGori, Frances Martin and Derick Henry E11EVEN PARTNERS is responsible for the ownership, marketing, management, and the creative direction of E11EVEN MIAMI and Rooftop. With over 150 years of combined experience between its partners, E11EVEN PARTNERS possesses one of the industry’s most dynamic leadership teams.

With its launch in 2014, E11EVEN ultraclub concept was the first of its kind, creating an unparalleled hospitality and nightlife experience for its guests. E11EVEN’s accolades include being awarded “Best New Nightclub Concept,” perennially voted among the top 10 nightclubs worldwide, and becoming the highest-grossing nightclub per square foot globally.

In addition to E11EVEN MIAMI, E11EVEN PARTNERS has continued to develop and expand the E11EVEN name & lifestyle with the creation of E11EVEN Brand; the E11EVEN Life hat and apparel line; E11EVEN Sound By Das Audio; E11EVEN Music; E11EVEN Captain’s Club; E11EVEN Vodka, for which they licensed its name; E11EVEN Crypto; and the new rooftop restaurant, Giselle.

E11EVEN PARTNERS is poised for growth and continued success with future projects in real estate, hospitality, and entertainment with their eye on the future.

Media Contact
For Madison Realty Capital:
Nathaniel Garnick/Grace Cartwright
Gasthalter & Co.
(212) 257-4170

For PMG:
Levy Public Relations

GlobeNewswire Distribution ID 8852810

Noted Vaccine Researcher Thomas P. Monath Awarded Sabin’s Gold Medal; Cameroon Physician Sangwe Clovis Nchinjoh Receives Rising Star Award

Sabin 2023 Gold Medal and Rising Star Awards

Sabin Vaccine Institute Chief Executive Officer Amy Finan (center) awarded the Sabin’s 30th Gold Medal Award to Dr. Thomas P. Monath (right) and Sabin’s 2023 Rising Star Award to Dr. Sangwe Clovis Nchinjoh of Cameroon on Monday, June 5, 2023 at the National Academy of Sciences in Washington, D.C.

WASHINGTON, June 06, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today awarded the 30th Albert B. Sabin Gold Medal Award to Thomas P. Monath, MD, and its Rising Star Award to Sangwe Clovis Nchinjoh, MD, MPH, in a ceremony at Washington D.C.’s National Academy of Sciences building.

Dr. Monath was selected for the Gold Medal for his more than four decades of commitment to advancing knowledge of arboviruses and vaccine research and development (R&D) that contributed to the development of several innovative vaccines including those for Ebola Zaire, smallpox, dengue, Japanese encephalitis and West Nile.

The Gold Medal, celebrating three decades of recognition, is Sabin’s highest scientific honor. It is given annually to a distinguished member of the global health community who has made exceptional contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. Barney Graham, Carol Baker, Bill Foege, Anne Gershon, Stanley Plotkin, and Kathrin Jansen.

“We are delighted to recognize Dr. Monath with our Gold Medal award for his lifelong commitment to prevent and control infectious disease and for his exemplary work on numerous vaccines that have benefitted humanity and saved lives,” says Amy Finan, Sabin’s chief executive officer. “His leadership in the vaccine field is unique in that he developed important vaccines as well as led public efforts to prepare for and address major global health threats.”

Dr. Thomas P. Monath, 30th Sabin Gold Medal Awardee

Dr. Thomas P. Monath was presented the 30th Sabin Gold Medal in a ceremony at the National Academy of Sciences in Washington, D.C. on Monday, June 5, 2023.

Dr. Monath said the Gold Medal stands out among the honors he has received over the years. “It was always my ambition to develop vaccines, make vaccines, do something tangible to help people. In my early career as an epidemiologist, I didn’t get a chance to develop the actual countermeasures that help save people’s lives, especially in underserved populations. That was the appeal that motivated me. It is a great honor to win this recognition, but that honor really rests on the contributions of my peers and many colleagues along the way.”

After serving as an epidemiologist and Director of the Division of Vector-Borne Viral Diseases at the Centers for Disease Control and Prevention (CDC), Dr. Monath moved to the U.S. Army to learn vaccine development first-hand and retired as colonel after serving as Chief of the Virology Division at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

In over 20 years in public service, he was deeply engaged in investigating emerging viral diseases, such as viral encephalitis, dengue, yellow fever, and Lassa fever, affecting underserved countries in Africa and Latin America. He was responsible for uncovering the rodent host reservoir of Lassa fever.

In the private sector, he developed a novel platform for vaccine development and brought four human vaccines and one veterinary vaccine through regulatory approval, including a second-generation smallpox vaccine. He has published more than 425 scientific papers, six books on virology and vaccine development, and has 35 patents to his name.

Sabin’s Rising Star is awarded to encourage and recognize the next generation of vaccine and immunization leaders. Dr. Nchinjoh, a physician, was selected for developing ground-breaking techniques to reach zero-dose children — those who have never received the protection of routine childhood vaccinations — in missed communities and conflict settings in Cameroon.

“With his focus on strengthening immunization and health services among some of our most neglected communities, Dr. Nchinjoh exemplifies the spirit behind the Rising Star award,” says Finan. “His contributions to identify and immunize zero-dose children in Cameroon serves as a model for other countries trying to reach those populations and can go a long way toward improving vaccination rates in much of the world.”

Dr. Sangwe Clovis Nchinjoh, Sabin 2023 Rising Star Awardee

Dr. Sangwe Clovis Nchinjoh of Cameroon was presented the 2023 Sabin Rising Star award at a ceremony at the National Academy of Sciences in Washington, D.C. on Monday, June 5, 2023.

“I am most proud of the ripple effects from this award,” says Dr. Nchinjoh. “It’s going to help to share what we’ve been doing all these years, share the lessons, and help stakeholders adopt new methods for reaching communities. It’s also going to touch a lot of people that I work with, who will be inspired by seeing that the work we do is appreciated.”

A public health researcher with more than five years of leading and coordinating high impact multi-stakeholder programs, Dr. Nchinjoh’s findings led to the development and testing of service delivery models in sample communities in all ten regions of Cameroon. More than 8,500 zero-dose children in 20 target health areas were reached, including increasing vaccination coverage from 0% to 70% in a hard-to-reach island in Manoka district.

For more about the recipients, see:

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit and follow us on Twitter, @SabinVaccine.

Media Contact:
Monika Guttman
Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 662-1841

Photos accompanying this announcement are available at

GlobeNewswire Distribution ID 8852911

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Global medical technology company will use Anaqua’s AQX to help consolidate and coordinate the management of all its IP assets

BOSTON, June 06, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company Getinge has selected Anaqua’s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.

Founded in Sweden in 1904, Getinge provides hospitals and life science institutions in 133 countries with products and solutions that aim to improve clinical results and optimize workflows.

Anna Maria Lagerqvist Gahm, Head of IP & Digital Law at Getinge, said: “With our extensive range of products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, life science and digital healthcare solutions and our strong international presence with operations in more than 40 countries worldwide, it was important to be able to improve the efficiency and coordination of our IP management by consolidating onto a centralized platform. AQX enables us to do that, while also providing highly integrated functionality in key areas such as analytics and invention management.”

Bob Romeo, CEO of Anaqua, said: “Getinge focuses on helping its customers save lives through the products and solutions it develops, and on achieving its goal of becoming the world’s most trusted and respected medtech company. We are delighted to be supporting Getinge on that journey by helping manage and protect the company’s valuable IP assets. Anaqua continues to invest in offerings to meet and exceed the ever-evolving demands of the world’s most innovative life science companies.”

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 11,000 people worldwide and the products are sold in 133 countries.

About Anaqua

Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX and PATTSY WAVE, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit, or on LinkedIn.

Company Contact:
Amanda Glagolev
Director, Communications

GlobeNewswire Distribution ID 8852728

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery

SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody and therapeutics development at Antibody Engineering and Therapeutics, Europe in Amsterdam, The Netherlands. In addition to the exhibition, Jason Lehmann, PhD Senior Product Marketing Manager at Telesis Bio will present “The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking Through Critical Synthesis Bottlenecks” in the opening day session.

The award winning BioXp® system and associated BioXp De novo kits and BioXp Select kits enable push-button, automated synthesis of gene fragments, clones, variant libraries and mRNA from input sequence or existing DNA. In May, Telesis Bio also introduced their first automated NGS Library Preparation kit for Plasmid Sequencing on the BioXp platform, further advancing the vision of the platform as a total solution for streamlining molecular biology workflows. The BioXp system empowers researchers in antibody therapeutics to overcome traditional bottlenecks in lead discovery programs and take control of their synthesis timelines by enabling automated and efficient synthesis and sequence confirmation of antibody candidates.

For more information on solutions for accelerating workflows in therapeutic antibody development, please visit

About Telesis Bio
Telesis Bio is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of the industry-standard Gibson Assembly® method and the first commercial automated benchtop DNA and mRNA synthesis system, Telesis Bio is enabling rapid, accurate and reproducible writing of DNA and mRNA for numerous downstream markets. The award-winning BioXp® system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. As a result, it delivers virtually error-free synthesis of DNA and RNA at scale within days and hours instead of weeks or months. Scientists around the world are using the technology in their own laboratories to accelerate the design-build-test paradigm for novel, high-value products for precision medicine, biologics drug discovery, vaccine and therapeutic development, genome editing, and cell and gene therapy. Telesis Bio is a public company based in San Diego. For more information, visit

Telesis Bio, the Telesis Bio logo, Gibson Assembly, and BioXp are trademarks of Telesis Bio Inc.

Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements and guidance regarding the anticipated use of proceeds from the financing, as well as statements regarding the future release and success of new and existing products and services. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include risks described in the section entitled Risk Factors and elsewhere in our Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission (SEC) on March 22, 2023, as amended on May 17, 2023 and in our Quarterly Report on Form 10-Q, which was filed with the SEC on May 12, 2023. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. Telesis Bio disclaims any obligation to update these forward-looking statements.

Jen Carroll
Vice President of Investor Relations

GlobeNewswire Distribution ID 8852864